Direct and indirect costs of influenza-like illness treated with and without oseltamivir in 15 European countries: a descriptive analysis alongside the randomised controlled ALIC4E trial - Li, X; Bilcke, J; van der Velden, AW; Bongard, E; Bruyndonckx, R; Sundvall, P-D; Harbin, NJ; Coenen, S; Francis, N; Bruno, P; Garcia-Sangenis, A; Glinz, D; et al. (Clinical Drug Investigation, 2021)